JP2014508164A5 - - Google Patents

Download PDF

Info

Publication number
JP2014508164A5
JP2014508164A5 JP2013556899A JP2013556899A JP2014508164A5 JP 2014508164 A5 JP2014508164 A5 JP 2014508164A5 JP 2013556899 A JP2013556899 A JP 2013556899A JP 2013556899 A JP2013556899 A JP 2013556899A JP 2014508164 A5 JP2014508164 A5 JP 2014508164A5
Authority
JP
Japan
Prior art keywords
seq
sequence
administering
reducing
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013556899A
Other languages
English (en)
Japanese (ja)
Other versions
JP6166858B2 (ja
JP2014508164A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/027480 external-priority patent/WO2012119072A2/en
Publication of JP2014508164A publication Critical patent/JP2014508164A/ja
Publication of JP2014508164A5 publication Critical patent/JP2014508164A5/ja
Application granted granted Critical
Publication of JP6166858B2 publication Critical patent/JP6166858B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013556899A 2011-03-02 2012-03-02 細胞内損傷の治療のための組成物および方法 Expired - Fee Related JP6166858B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161448446P 2011-03-02 2011-03-02
US61/448,446 2011-03-02
PCT/US2012/027480 WO2012119072A2 (en) 2011-03-02 2012-03-02 Compositions and methods for treatment of intracellular damage

Publications (3)

Publication Number Publication Date
JP2014508164A JP2014508164A (ja) 2014-04-03
JP2014508164A5 true JP2014508164A5 (cg-RX-API-DMAC7.html) 2015-04-23
JP6166858B2 JP6166858B2 (ja) 2017-07-19

Family

ID=46758515

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013556899A Expired - Fee Related JP6166858B2 (ja) 2011-03-02 2012-03-02 細胞内損傷の治療のための組成物および方法

Country Status (5)

Country Link
US (3) US9737585B2 (cg-RX-API-DMAC7.html)
EP (1) EP2680872B1 (cg-RX-API-DMAC7.html)
JP (1) JP6166858B2 (cg-RX-API-DMAC7.html)
IL (1) IL228205B (cg-RX-API-DMAC7.html)
WO (1) WO2012119072A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7723290B2 (en) 2004-10-22 2010-05-25 Bioincept, Llc Compositions and methods for modulating the immune system
US9737585B2 (en) 2011-03-02 2017-08-22 Bioincept, Llc Compositions and methods for treatment of intracellular damage and bacterial infection
WO2017039751A1 (en) * 2015-08-28 2017-03-09 Bioincept, Llc Mutant peptides and methods of treating subjects using the same
EP3060924B1 (en) * 2013-10-22 2022-06-01 Bioincept LLC Pif-transfected cells and methods of use
CA2961375A1 (en) * 2014-09-16 2016-03-24 Bioincept, Llc Compositions and methods for treating acute radiation syndrome
JP2017535794A (ja) * 2014-11-03 2017-11-30 バイオインセプト、エルエルシー 免疫調節不全についてのマーカーとしてのｐｉｆ結合
TWI701249B (zh) 2015-03-13 2020-08-11 德商４Ｓｃ製藥公司 Ｋv１.３抑制劑及其醫學應用
TWI698438B (zh) 2015-03-13 2020-07-11 德商４Ｓｃ製藥公司 Ｋv１.３抑制劑及其醫學應用
US11090355B2 (en) 2015-08-28 2021-08-17 Bioincept, Llc Compositions and methods for the treatment of neurodamage
CA3071012A1 (en) * 2017-07-17 2019-01-24 Bioincept, Llc Peptides and methods of transplantation and restorative organ function

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352694B1 (en) 1994-06-03 2002-03-05 Genetics Institute, Inc. Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
US5658792A (en) 1990-11-14 1997-08-19 The United States Of America As Represented By The Department Of Health And Human Services Antiproliferative protein
IL96499A0 (en) 1990-11-28 1991-08-16 Eytan Barnea Anticancer protein-like extract
US5648340A (en) 1991-10-31 1997-07-15 Barnea; Eytan R. Gestational agents for controlling cell proliferation
US5393534A (en) 1992-04-09 1995-02-28 Board Of Regents, The University Of Texas System Liver-derived tumor cell growth inhibitor
US5279941A (en) 1992-06-12 1994-01-18 Trustees Of The University Of Pennsylvania Determination of endometrial receptivity toward embryo implantation
WO1994006464A1 (en) 1992-09-17 1994-03-31 New York University Compositions and methods for inhibiting hepatocyte invasion by malarial sporozoites
US5891623A (en) 1992-11-09 1999-04-06 Consorzio Per Le Biotecnologie Diagnosis and treatment of AIDS onset
DE4400640A1 (de) 1994-01-12 1995-07-13 Eftag Entstaubung Foerdertech Verwendung von, Mittel mit und Verfahren zur Herstellung eines Arzneimittels mit Embryonalgewebe
US5646003A (en) 1994-03-23 1997-07-08 Barnea; Eytan R. Preimplantation factor
GB9406492D0 (en) 1994-03-31 1994-05-25 Isis Innovation Malaria peptides
US6489441B1 (en) 1995-09-01 2002-12-03 The Salk Institute For Biological Studies Transcriptional co-repressor that interacts with nuclear hormone receptors
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
SE9701912D0 (sv) 1997-05-22 1997-05-22 Interhealth Ab Pharmaceutical composition and use thereof
US6225097B1 (en) 1997-09-17 2001-05-01 Toyota Jidosha Kabushiki Kaisha Decaprenyl diphosphate synthetase gene
US6171591B1 (en) 1997-12-08 2001-01-09 Pentamer Pharmaceuticals, Inc. Recombinant nodavirus compositions and methods
KR19990075721A (ko) 1998-03-24 1999-10-15 허일섭 당뇨병 특이 변이종 내인성 레트로바이러스의 유전자 및이로부터 유추되는 아미노산 서열
WO2000001402A1 (en) 1998-07-02 2000-01-13 Envision Biomedical Consulting Antiproliferative and antiviral proteins and peptides
EP1265582A2 (en) 1999-09-29 2002-12-18 Human Genome Sciences, Inc. Colon and colon cancer associated polynucleotides and polypeptides
AU7854400A (en) 1999-10-08 2001-04-23 Envision Biomedical Consulting Gestational agents which modulate cell proliferation
US20020004205A1 (en) 2000-03-30 2002-01-10 Consler Thomas G. Method of investigating functional molecular interactions and reagents for use therein
UA74575C2 (uk) 2000-05-01 2006-01-16 Sanders John Larry Аніонні полімери на основі вінілу і дикарбонової кислоти, способи їх одержання (варіанти), композиція на їх основі та способи посилення росту рослин за їх допомогою
US7198895B2 (en) 2000-11-14 2007-04-03 Mohanlal Ramon W In vitro cell-based methods for biological validation and pharmacological screening of chemical entities and biologicals
MXPA03006043A (es) 2001-01-04 2004-01-26 Vascular Biogenics Ltd Metodos que emplean y composiciones que contienen moleculas asociadas en placa para la prevencion y el tratamiento de la aterosclerosis.
US20030105003A1 (en) * 2001-04-05 2003-06-05 Jan Nilsson Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
CN100339388C (zh) 2001-07-02 2007-09-26 倍奥英赛普特有限责任公司 用于植入前因子的新型检测方法以及植入前因子肽
US8222211B2 (en) 2001-07-02 2012-07-17 Bioincept, Llc Methods of administering PIF agonist peptides and uses thereof
US20060104963A1 (en) 2002-07-25 2006-05-18 The Scripps Research Institute Treatment of cone cell degeneration with transfected lineage negative hematopoietic stem cells
US8017745B2 (en) 2002-12-06 2011-09-13 Epimmune Inc. Plasmodium falciparum antigens and methods of use
JP4719151B2 (ja) * 2003-09-23 2011-07-06 メルク・シャープ・エンド・ドーム・コーポレイション イソキノリノンカリウムチャネル阻害剤
EP1667982B1 (en) 2003-09-23 2013-07-31 Merck Sharp & Dohme Corp. Isoquinolinone potassium channel inhibitors
US7723289B2 (en) 2003-10-22 2010-05-25 Bioincept, Llc PIF tetrapeptides
NZ547139A (en) 2003-10-22 2009-12-24 Bioincept Llc Use of preimplantation factor peptides to treat intolerence to embryo implantation
US7723290B2 (en) * 2004-10-22 2010-05-25 Bioincept, Llc Compositions and methods for modulating the immune system
CA2614039C (en) 2005-07-22 2015-10-13 Five Prime Therapeutics, Inc. Compositions and methods of treating disease with fgfr fusion proteins
WO2009120186A1 (en) * 2008-03-24 2009-10-01 Carolus Therapeutics, Inc. Methods and compositions for treating atherosclerosis and related conditions
US9737585B2 (en) 2011-03-02 2017-08-22 Bioincept, Llc Compositions and methods for treatment of intracellular damage and bacterial infection

Similar Documents

Publication Publication Date Title
JP2014508164A5 (cg-RX-API-DMAC7.html)
US10722562B2 (en) Combinatorial analysis and repair
CO2020001113A2 (es) Muteínas de interleucina 21 y métodos de tratamiento
PE20240645A1 (es) Peptido inmunogenico derivado de moleculas de antigenos leucocitarios humanos (hla) como biomarcador en la inmunoterapia de diversos tumores
JP2013503205A5 (cg-RX-API-DMAC7.html)
JP2011250797A5 (cg-RX-API-DMAC7.html)
JP2010516290A5 (cg-RX-API-DMAC7.html)
JP2010519289A5 (cg-RX-API-DMAC7.html)
JP2016040284A5 (cg-RX-API-DMAC7.html)
EA201490852A1 (ru) Ингибиторы рециркуляции желчных кислот для лечения гиперхолемии и холестатического заболевания печени
RU2010151725A (ru) Аминокислотные последовательности, направленные против cхcr4 и других gpcr, и соединения, включаюшие их
JP2013503110A5 (cg-RX-API-DMAC7.html)
RU2017104529A (ru) Композиции neisseria meningitidis и способы их применения
RU2014112343A (ru) Оставы антигенов staphylococcus aureus, содержащие адъюванты
JP2011173914A5 (cg-RX-API-DMAC7.html)
UY32599A (es) Formulación oral sólida de abt-263
JP2009017881A5 (cg-RX-API-DMAC7.html)
RU2016111934A (ru) Иммуногенные композиции коронавируса ближневосточного респираторного синдрома (mers-cov) и способы
EP2543727A4 (en) MODIFIED ANTIBODY COMPOSITION
RU2011123700A (ru) Нонапептид с противоопухолевой активностью
EP3862017A1 (en) Peptide possessing mesenchymal-stem-cell mobilizing activity
JP2012515213A5 (cg-RX-API-DMAC7.html)
JP2009537507A5 (cg-RX-API-DMAC7.html)
EA201391200A1 (ru) Способы и композиции для вакцинации от staphylococcus aureus
BR112014009910A2 (pt) formulações de sal de meglumina de ácido 1-(5,6-dicloro-1h-benzo[d]imidazol-2-il)-1h-pirazol-4-carboxílico